Establishment and application of a drug performance appraisal system based on the performance appraisal for tertiary public hospitals / 中华医院管理杂志

ABSTRACT

The performance appraisal for tertiary public hospitals provides means for the rational management of drug use in public hospitals. Starting from October 2021, Hospital Z had established a drug performance appraisal system based on the relevant requirements for rational drug use in the performance appraisal for tertiary public hospitals, in view of the actual situation. The system included four indexes: weighted outpatient per capita drug cost, weighted inpatient per capita drug cost, rational drug use rate, and intensity of antibacterial drug use. Different scores were assigned to each indexi and scoring methods were developed. By dividing all drugs in the hospital medication catalog into three categories A, B, and C and assigning them different weights, as well as setting reasonable target values for each indexi, the hospital guided clinical departments to use drugs rationally. The proportion of drugs in hospital Z decreased from 28.75% in 2020 to 25.44% in 2022, the proportion of medical service revenue increased from 22.97% to 28.40%, the per capita outpatient drug cost decreased from 170 yuan to 166 yuan, and the per capita inpatient drug cost decreased from 7 318 yuan to 5 983 yuan. The number of departments with a 100% reasonable drug use rate increased from 11 in September 2021 to 16 in September 2022, and the intensity of antibacterial drug use decreased by 35.84%. The opplication of this drug performance appraisal system partly optimized the hospital′s income structure, controlled the growth of drug costs, promoted the rational use of drugs, so as to provid references for the rational drug use management of tertiary public hospitals.